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Optimizing the collagenase G (ColG):collagenase H (ColH) ratio is a key strategy for achiev-
ing tailored donor-tissue specific islet isolation. Collagen V (Col V) and collagen III (Col III)
are crucial target matrices of ColG and ColH, respectively. We herein investigated the rele-
vance between the expression of target matrices in pancreatic tissues and influence of
ColG:ColH ratio on islet isolation outcome.
Methods
Islet isolation was performed in Lewis and SD rats using different ColG:ColH ratios (5:1, 1:1
and 1:5; n = 7/group). The composition of Col III and Col V was examined using immunohisto-
chemical staining, real-time polymerase chain reaction (PCR), Western blotting and mass
spectrometry. Chain types in collagen I (Col I) were also assessed using mass spectrometry.
Results
No beneficial effects were observed by increasing the ColG amount, irrespective of the rat
strain. In contrast, the islet yield in Lewis rats was considerably increased by high amounts
of ColH but decreased in SD rats, suggesting that Lewis pancreas contains more Col III
than SD pancreas. Neither immunohistochemical nor real-time PCR showed correlation
with isolation outcome. However, Western blotting revealed that Lewis contained consider-
ably higher amount of Col III than SD (p = 0.10). Likewise, Col-I(α1)/Col-III(α1) and Col-I
(α2)/Col-III(α1) were significantly lower in Lewis than in SD rats (p = 0.007, respectively).
Furthermore, the isolation outcome was considerably correlated with the composition of
homotrimeric Col I.
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Conclusions
The Col III expression and the composition of homotrimeric Col I in pancreatic tissues deter-
mined using mass analyses appeared useful for optimizing the ColG:ColH ratio in islet
isolation.
Introduction
Although pancreatic islet transplantation is a promising and safe therapy for type 1 diabetic
patients[1, 2], many issues remain to be solved. For example, pancreata from two or more
donors are required for one diabetic patient to achieve insulin independence in many cases,
despite improvements in human pancreatic islet isolation procedures over the past three
decades [3–6]. Furthermore, the successful islet isolation rate has increased through appropri-
ate donor selection, but the successful islet isolation rate of whole donor pancreata is still poor
[7, 8]. A more efficient islet isolation procedure may increase the islet yield from one donor
pancreas and solve such problems, helping relieve the organ shortage issue.
An important factor associated with the outcome of islet isolation is the tissue dissociation
enzyme [4, 9, 10]. A donor-specific, individualized, islet isolation protocol can theoretically be
established if highly purified components of tissue dissociation enzyme were prepared to target
the extracellular matrix of each enzyme component.
Enzymes currently used for pancreatic islet isolation include collagenase, neutral protease
and other unknown components. Collagenases, produced by Clostridium histolyticum (C. his-
tolyticum), are the main components of the islet isolation enzyme combination. These collage-
nases are consisted of six different collagenases, and they are divided into two groups;
collagenase G (ColG) and collagenase H (ColH) [11, 12]. ColG (corresponding to Class I colla-
genases) has a high activity toward native collagen and a moderate activity toward 2-furanacry-
loyl-L-leucylglycyl-L-prolyl-L-alanine (FALGPA), whereas ColH (corresponding to Class II
collagenases) has a moderate activity toward collagen and a high activity toward FALGPA
[11]. We have successfully produced tryptic-like activity (TLA)-free enzyme preparations of
highly purified recombinant collagenase of each subtype to examine the roles of ColG and
ColH in islet isolation [13–15], given Brandhorst et al.’s finding that some unknown proteases
other than collagenases and neutral proteases, which have a high TLA, might affect pancreas
dissociation [16]. Using these novel collagenases, we clearly showed that ColH is crucial for rat
pancreatic islet isolation [13].
We also reported that collagen III (Col III) is a key target matrix of ColH using highly puri-
fied recombinant collagenases [13]. Given that Col III is most intensely expressed in the exo-
crine tissues, with almost no expression in the peri-insular region [13], islet isolation is likely
initiated by fragmentation of the pancreatic tissues by ColH mainly via the degradation of Col
III. We recently demonstrated that collagen V (Col V) is only digested by ColG and not by
ColH, and that Col V is a key substrate for ColG [17]. Given these findings, we hypothesized
that the semi-quantitative assessment of Col III and V in pancreatic tissues might aid in suc-
cessful islet isolation by directing the optimization of the ColG and ColH levels.
To achieve a tailor-made type of donor tissue specific islet isolation procedure, we investi-
gated the relationship between the islet isolation outcome and different rat strains using vari-
able ColG:ColH ratios. We also evaluated the Col III and Col V expression in pancreatic
tissues of different rat strains using immunohistochemical (IHC) staining, real-time
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polymerase chain reaction (PCR), Western blotting and mass spectrometry and correlated the
findings with the influence of the ColG:ColH ratio on the islet isolation outcome.
We believe that the findings of the present study may open the way to establish the most
suitable combination of tissue dissociation enzyme components for any type of donors, espe-
cially for young donors and highly fibrotic pancreata that have been well known to cause poor
outcome of islet isolation.
Materials and methods
Animals
Rat pancreata were obtained from 9-week-old inbred Lewis rats and 8-week-old closed colony
SD rats (Japan SLC, Inc., Shizuoka, JAPAN). All animals used in this present study were
treated according to the Guide for the Care and Use of Laboratory Animals published by the
National Institutes of Health. The protocol was approved by the ethics committee for animal
experiments and related activities of Tohoku University (approved protocol ID: 2016 Medical-
Animal-197). All surgical procedures were performed under inhalation anesthesia using iso-
flurane, and every effort was made to reduce suffering. All animals were sacrificed with deep
anesthesia and bleeding caused by cutting inferior vena cava.
Enzyme preparation
Recombinant ColG and ColH (Meiji Seika Pharma Co., Ltd., Tokyo, Japan) were used with
thermolysin (TL) as a neutral protease (Peptide Institution, Inc., Osaka, Japan) to prepare the
enzyme blends. The activity of TL (0.065 mg) was adjusted to that of the crude collagenase from
C. histolyticum (Sigma collagenase type V; Sigma-Aldrich, St. Louis, MO, USA) using Azocasein
(Sigma-Aldrich Japan, Tokyo, Japan). The activities of ColG and ColH were calculated using
FALGPA and Azocoll (Calbiochem, Merck Millipore, Darmstadt, Germany). We calculated the
protein amount of ColG and ColH when their activities in the enzyme blends were equal to
those of Sigma collagenase type V. Each rat strain was divided into three groups regarding the
ratio of ColG to ColH (5:1, 1:1 and 1:5 groups). The ratio was calculated using the protein
amount of each collagenase, and the total protein amount of ColG and ColH was adjusted 20%
(1.49 mg) to that calculated from Sigma collagenase Type V (5:1 group: ColG 1.242 mg, ColH
0.248 mg; 1:1 group: ColG 0.745 mg, ColH 0.745 mg; 1:5 group: ColG 0.248 mg, ColH 1.242
mg). All enzyme blends were diluted in Hanks’ Balanced Salt Solution (HBSS).
Islet isolation
Rat islet isolation was performed as previously described [18]. After cannulating the bile duct, 10
mL of cold HBSS containing the enzyme blends was injected followed by the removal of the pan-
creas. After digestion at 37˚C for 14 min, purification by a density-gradient centrifugation was
performed using a Histopaque-1119 (Sigma Diagnostics, St. Louis, MO, USA) and Lymphoprep
(Axis-Shield PoC AS, Oslo, Norway). The islet count was determined as islet equivalents (IEQs)
with diphenylthiocarbazone (Wako Pure Chemical Industries, Ltd., Osaka, Japan) staining. The
isolated islets were cultured in Roswell Park Memorial Institute-1640 medium containing 5.5
mmol/L glucose (Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 10% fetal bovine
serum (Equitech-Bio, Inc., Kerrville, TX, USA) at 37˚C in 5% CO2 and humidified air.
Immunohistochemical staining of rat pancreatic tissues
Rat pancreatic tissues were cut into small sections, embedded into Tissue-TK O.C.T. Com-
pound (Sakura Finetek USA, Inc., Torrance, CA, USA) and frozen with liquid nitrogen after
Strategy towards donor specific islet isolation
PLOS ONE | https://doi.org/10.1371/journal.pone.0216136 May 10, 2019 3 / 14
fat tissues, vessels and lymph nodes were removed. We obtained 8-μm slices from the frozen
pancreatic tissue and placed them in 4% paraformaldehyde for 10 min at room temperature.
The slides were pretreated with 5 mg/mL of pepsin (Dako, Agilent Technologies, Inc., Santa
Clara, CA, USA) at 37˚C for 10 min for antigen retrieval, and with 10% bovine serum albumin
(Sigma-Aldrich) for 20 min at room temperature to block non-specific antibody reaction.
Antibodies against Col III (Anti-Collagen III antibody; Abcam PLC, Cambridge, UK) and Col
V (Anti-Collagen V antibody; Abcam) were used as primary antibodies for immunolabeling at
1:80 and 1:100 dilutions in phosphate-buffered saline (PBS) respectively. As a secondary anti-
body, EnVision System-HRP Labelled Polymer Anti-Rabbit (Dako, Agilent Technologies) was
used, followed by localization of antibody bindings with diaminobenzidine (Trevigen, Inc.,
Gaithersburg, MD, USA). Slides were washed twice with PBS between each process. In all
slices, the percentage of the stained area was calculated using the Image J software program,
ver. 1.51n (National Institute of Health, Bethesda, MD, USA) [19].
Col3a1 and Col5a1 mRNA in pancreatic tissues
Pancreatic tissues were obtained from each rat strain (n = 5, respectively) under anesthesia
and immediately placed in RNAlater (QIAGEN, Hilden, Germany) after removing fat tissues,
vessels and lymph nodes. Samples were then cut into small sections and frozen in liquid nitro-
gen. Total RNA was extracted using the RNeasy Mini Kit (QIAGEN) according to the manu-
facturer’s protocol. The RNA extraction quality was evaluated by the ratio of absorbance at 260
nm/280 nm. First-strand complementary DNA (cDNA) was synthesized from 2.5 μg of total
RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Indianapo-
lis, IN, USA). The cDNA was amplified by PCR using a rat Col3a1 primer and a probe (5’ to 3’
direction forward primer: ATG AGC TTT GTG CAA TGT GG, 5’ to 3’ direction reverse
primer: CTA GAC TCA TAG GAC TGA CCA AG, 5’ to 3’ direction probe: FAM-CCT GGT
TTC TTC TCA CCC TGC TTC ACC-TAMRA) (Nihon Gene Research Laboratories Inc.,
Sendai, Japan), rat Col5a1 primer and a probe (5’ to 3’ direction forward primer: TGT GCC
ACT CGA CGA TCT, 5’ to 3’ direction reverse primer: GTC CTC AGG AAA GTC AGA
CTC A, 5’ to 3’ direction probe: FAM-CCA AAG AGC CGG ATG TTG CCT ACC-TAMRA)
(Nihon Gene Research Laboratories), and rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) primer and a probe (Nihon Gene Research Laboratories) as housekeeping gene
with a LightCycler FastStart DNA Master HybProbe (Roche Diagnostics) and LightCycler 2.0.
To perform the PCR for Col3a1 and Col5a1, an initial denaturation step of 10 minutes at 95˚C
was followed by 45 cycles of 10 seconds at 95˚C, annealing and extension of 30 seconds at
60˚C. For GAPDH, an initial denaturation step of 10 minutes at 95˚C was followed by 40
cycles of 10 seconds at 95˚C, annealing and extension of 60 seconds at 60˚C.
Western blotting of Col III in pancreatic tissues
Pancreatic tissues were obtained from each rat strain (n = 5, respectively) under anesthesia and
frozen in liquid nitrogen after removing fat tissues, vessels and lymph nodes. A small section of
pancreas was obtained from several random locations and placed in PBS (7.5 μl of liquid per
one milligram of tissue) containing 5 mM AEBSF (Nacalai Tesque, Inc., Kyoto, Japan), 4 μM
Aprotinin (Nacalai Tesque), 75 μM E-64 (Nacalai Tesque), 100 μM Leupeptin (Nacalai Tesque),
250 μM Bestatin (Nacalai Tesque), 50 μM Pepstatin A (Nacalai Tesque), 10 mM EDTA (Nacalai
Tesque), 1 mM TLCK (Nacalai Tesque), and 1 mM TPCK (Wako Pure Chemical Industries).
The samples were homogenized using POLYTRON PT 10–35 (Kinematica AG, Luzern, Swit-
zerland) at 10,000 rpm for 1 min repeated 5 times each. After homogenization, the suspension
was mixed with one quarter of 1 M hydrochloric acid (Nacalai Tesque) and left on ice for 60
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minutes while stirring with vortex every 10 minutes. After centrifuging at 4˚C and 15,000 g for
10 min, the supernatant was collected. The concentration of protein in supernatants were mea-
sured using a BCA Protein Assay kit (Thermo Fisher Scientific, Inc.). Protein contained in the
supernatant was precipitated by adding trichloroacetic acid, and after centrifuging at 4˚C and
15,000 g for 20 min, the precipitate was suspended in SDS buffer, containing 1.2% SDS (Nacalai
Tesque), 60 mM Tris-HCl buffer (pH 6.8), 12% glycerol (Nacalai Tesque), 0.04% BPB (Nacalai
Tesque), and 10% 2-mercaptoethanol (Nacalai Tesque), at 5 mg/ml or 1 mg/ml and boiled for 5
minutes. The 20 μl of 5 mg/ml and 10 μl of 1 mg/ml sample solutions were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in the col III analysis and the
β-actin analysis, respectively. SDS-PAGE was performed using a 7.5% polyacrylamide slab gel
for the col III analysis and 12.5% for the β-actin analysis, respectively. The separated proteins
were transferred onto polyvinylidene fluoride membranes (Bio-Rad Laboratories, Inc., Hercu-
les, CA, USA) using a Trans-Blot SD semi-dry transfer cell (Bio-Rad Laboratories). The mem-
brane was reacted with Anti-Collagen III antibody (catalog No. ab7778, Abcam) or Anti-β-actin
antibody (catalog No. ab8227, Abcam) as the primary antibody. The secondary antibody was
alkaline phosphatase-conjugated goat anti-rabbit IgG (catalog No. ab6722, Abcam) and signals
were detected using nitro blue tetrazolium (Nacalai Tesque) and 5-bromo-4-chloro-3-indolyl
phosphate. The scanned and captured bands were analyzed using ImageJ 1.52a software devel-
oped at the National Institutes of Health [19].
Western blotting of Col V in pancreatic tissues
Pancreatic tissues were obtained from each rat strain (n = 5, respectively) under anesthesia
and frozen in liquid nitrogen after removing fat tissues, vessels and lymph nodes. A small sec-
tion of pancreas was obtained from several random locations and placed in 1000 μL of PBS
containing 5 mmol/L EDTA (Nacalai Tesque), 10 mmol/L benzamidine (Merck Millipore)
and 0.1 mg/mL soybean trypsin inhibitor (Sigma-Aldrich), and 10 μL of 99.5% ethyl alcohol
containing 100 mmol/L phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich). The samples
were homogenized using PT1300E (Kinematica AG) and VCX-130 (Sonics and Materials,
Inc., Newtown, CT, USA) for 1 min each. After centrifuging at 4˚C and 3,400 rpm for 10 min,
the supernatant was collected and stored at -80˚C. The concentration of protein in superna-
tants were measured using a BCA Protein Assay kit (Thermo Fisher Scientific) and adjusted to
1mg/mL with NOVEX Tris-Glycine SDS Sample Buffer (Thermo Fisher Scientific). The sam-
ples were separated by SDS-PAGE using Novex 4–12% Tris-Glycine Mini Gels, WedgeWell
format (Thermo Fisher Scientific) and Novex Tris-Glycine SDS Running Buffer (Thermo
Fisher Scientific). The separated samples were transferred to PVDF Pre-cut Blotting Mem-
branes (Thermo Fisher Scientific), which were blocked by ECL Prime Blocking Reagent (GE
Healthcare UK Ltd., Amersham, UK). Thereafter, the membranes were incubated with Anti-
Collagen V (catalog No. ab114072, Abcam) and anti-β-actin antibody (catalog No. ab8227,
Abcam) at 4˚C overnight, and Goat Anti-Rabbit IgG H&L (HRP) (catalog No. ab205718,
Abcam) was used as second antibody for 60 min at room temperature. The bands were visual-
ized by Amersham ECL Prime (GE Healthcare Ltd., UK) and analyzed using a Molecular
Imager VersaDoc MP 5000 System (Bio-Rad Laboratories).
In vitro digestion of pancreatic tissues
Pancreatic tissues were prepared for each rat strain (Lewis and SD). Tissues (n = 8 for each
rat strain) were divided into small pieces (typically 40–60 mg) on ice. The tissue pieces were
then homogenized with Micro Smash MS-100R (TOMY MEDICO, Tokyo, Japan) with
stainless beads (φ 3mm). The homogenized solutions were subsequently applied to the
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CNMCS compartmental protein extraction kit (Millipore, Billerica, MA, USA) to enrich
collagens [20, 21]. The samples were digested using S-Trap: Rapid Universal MS Sample
Prep (PROTIFI, Huntington, NY, USA) with trypsin according to the manufacturer’s
instructions.
Liquid chromatography with tandem mass spectrometry of collagens
The digested samples were applied to MS analyses. The liquid chromatography with tandem
MS (LC-MS) system comprised a PAL HTC-xt autosampler (AMR Inc., Tokyo, Japan) and
Ultimate 3000 pump (Thermo Fisher Scientific) connected to a C18 tip column (10 cm
length and 75 μm inner diameter, Nikkyo Technos Co., Ltd. Tokyo, Japan), and Orbitrap
LTQ-Velos (Thermo Fisher Scientific). Raw data were processed with the Proteome Discov-
erer version 1.4.1.14 (Thermo Fisher Scientific) using the standard workflow. A database
search was performed using the Mascot search engine (version 2.6.0, Matrix Science, Lon-
don, UK) against SwissProt. Quantitative evaluations were conducted using an emPAI
index [22].
Statistical analyses
All values were expressed as the mean ± standard deviation and analyzed using the JMP Pro
software program, ver. 13.1.0 (SAS Institute Inc., Cary, NC, USA). Data from two groups were
compared using Mann-Whitney U test. Data from three groups were compared using Krus-
kal-Wallis test and Steel-Dwass test as a post hoc test. A value of p< 0.05 was considered to
indicate statistical significance.
Results
Effects of the collagenase subtype (ColG:ColH) ratio on the islet yield by rat
strains
To clarify the effects of the collagenase subtype ratio on the islet yield, the exact same lot
and amount of TL was used for all experimental groups. The islet yield was not increased
by a high amount of ColG in either strain (Fig 1). In contrast, the yield was considerably
increased by a high amount of ColH in the Lewis rats (ColG:ColH (1:1): 1799.2 ± 753.4
IEQs, ColG:ColH (1:5): 2254.9 ± 555.4 IEQs, p = 0.09, n = 7), but tended to decrease in the
SD rats (ColG:ColH (1:1): 944.6 ± 248.5 IEQs, ColG:ColH (1:5): 732.2 ± 658.2 IEQs, n = 7)
(Fig 1). In all groups of both rat strains, the function of isolated islets was not affected in
FDA/PI analysis (data are not shown).
Immunohistochemical staining of rat pancreatic tissues
The percentage of Col III- and V-stained areas in the whole tissues of SD rats was significantly
higher than in those of Lewis rats (collagen III: 22.8% ± 3.1% vs. 20.0% ± 4.6%, p<0.001, colla-
gen V: 24.3% ± 2.9% vs. 20.0% ± 1.9%, p<0.001) (Figs 2B and 3B). No marked differences
were observed in the Col III and V staining in the peri-insular regions between the strains
(Figs 2C and 3C).
mRNA expression of Col3a1 and Col5a1 in rat pancreatic tissues
The Col3a1 and Col5a1 mRNA levels in rat pancreatic tissues were similar between the Lewis
and SD groups (Col3a1/GAPDH: Lewis 0.628 ± 0.302 vs. SD 0.579 ± 0.231, P = 0.92; Col5a1/
GAPDH: Lewis 0.095 ± 0.041 vs. SD 0.085 ± 0.030, P = 0.92) (Fig 4A and 4B).
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Protein expression of collagen III and collagen V in rat pancreatic tissues
The Col III protein expression in the Lewis rat pancreatic tissues was considerably higher than
in the SD rat tissues (100.0 ± 0.0 vs. 84.7 ± 47.3, p = 0.10, n = 5) (Fig 5A and 5B). However, no
marked difference was detected between the two groups in terms of the Col V expression (Fig
5C and 5D).
Quantitative analyses of collagens in rat pancreatic tissues by MS
In the MS analyses of collagens, the α1 and α2 chains of collagen type I (Col-I(α1) and Col-I
(α2)) and the α1 chain of collagen type III (Col-III(α1)) were detected in all samples. Quantita-
tive analyses were conducted for relative values using the ratio Col-I(α1)/Col-III(α1), Col-I
(α2)/Col-III(α1) and Col-I(α1)/Col-I(α2). Fig 6 shows the collagen ratios evaluated from the
emPAI index. On comparing the Lewis and SD rats, Lewis rats had significantly lower values
for Col-I(α1)/Col-III(α1) and Col-I(α2)/Col-III(α1) than SD rats (Col-I(α1)/Col-III(α1):
1.467 ± 1.102 vs. 3.546 ± 1.534, p = 0.007, n = 8; Col-I(α2)/Col-III(α1): 0.605 ± 0.462 vs.
1.907 ± 1.109, p = 0.007, n = 8) (Fig 6A and 6B). These values indicate two possibilities: (1)
Col-III(α1) content is Lewis > SD, or (2) Col-I(α1) and Col-I(α2) content are Lewis < SD.
Collagen type I exists as a trimeric form consisting of two α1 chains and one α2 chain (het-
erotrimer) or three α1 chains (homotrimer) [23]. Assuming a complete heterotrimer, the chain
ratio of Col-I(α1)/Col-I(α2) should be two, so a mixture of two forms should show a chain ratio
of more than two. Our results indicated that Col I exists as a mixture of the two forms, with a
ratio (homotrimer/heterotrimer) of 0.186:1 for Lewis rats and 0.044:1 for SD rats.
Discussion
To establish a tailor-made donor tissue-specific islet isolation protocol, two factors appear to
be essential. The first is a highly purified tissue dissociation enzyme. If poorly characterized
unknown proteases derived from C. histolyticum are included in the dissociation enzyme, the
Fig 1. Effects of the ColG:ColH ratio on the islet yield for each rat strain. The islet yields of the 5:1 (white) and 1:5
(gray) groups are presented as the percentage when the yield of the 1:1 group (dotted) was considered 100% in each
strain.
https://doi.org/10.1371/journal.pone.0216136.g001
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equation between the dissociation enzyme and target matrix will not work efficiently. The sec-
ond crucial factor is identifying the target extracellular matrix of each enzyme component. We
previously reported that Col III is a key target matrix of ColH [13], and Col V is a key substrate
for ColG using highly purified recombinant collagenase of each subtype [17]. Based on these
novel findings, we investigated the relationship between Col III and Col V expression in pan-
creatic tissues and influence of ColG:ColH ratio on islet isolation outcome in different rat
strain. Our data suggested that the Col III expression and/or the composition of homotrimeric
Col I in pancreatic tissues may be useful for optimizing the ColG:ColH ratio in islet isolation.
We observed no beneficial effects by increasing the ColG amount irrespective of the rat
strain. This tendency was consistent with previous reports [13, 24]. In contrast, the depen-
dency on the ColH component seemed to be distinct between the two strains. Given that Col
III was a key target matrix of ColH in our previous study [13], the Col III expression in Lewis
pancreatic tissues may be higher than that in SD rats. A semi-quantitative analysis using MS
showed that Lewis rats had significantly lower Col-I/Col-III ratios, thereby suggesting two
Fig 2. Anti-collagen III staining of the pancreatic tissues in each rat strain. (A) Anti-collagen III staining (a and b:
Lewis rat; c and d: SD rat). The stained area was calculated using pictures without hematoxylin staining (b, d). (B) The
percentage of the over-all anti-collagen III-stained area. (C) The percentage of the anti-collagen III-stained area in the
peri-insular region only.
https://doi.org/10.1371/journal.pone.0216136.g002
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Fig 3. Anti-collagen V staining of the pancreatic tissues in each rat strain. (A) Anti-collagen V staining (a and b:
Lewis rat; c and d: SD rat). The stained area was calculated using pictures without hematoxylin staining (b, d). (B) The
percentage of the overall anti-collagen V-stained area. (C) The percentage of the anti-collagen V-stained area in the
peri-insular region only.
https://doi.org/10.1371/journal.pone.0216136.g003
Fig 4. Real-time PCR analyses of the Col3a1 and Col5a1 mRNA expression in the pancreatic tissues of each rat
strain. (A) Col3a1/GAPDH ratio. (B) Col5a1/GAPDH ratio. In all analyses, GAPDH was used as a housekeeping gene.
https://doi.org/10.1371/journal.pone.0216136.g004
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possibilities: (1) Col-III content is Lewis > SD, and/or (2) Col-I content is Lewis < SD. Given
that Western blot analyses also showed that the Col III protein expression in the Lewis rat pan-
creatic tissues was considerably higher than that in the SD rats, it seems more likely the former
is the case in the present study. Given that Col I is known to be broadly and abundantly
expressed in most tissues, this interpretation makes sense.
In the MS analyses, we detected relative amounts of Col I for α1 and α2 chains. Almost no
studies have explored the difference in the chain types in Col I. Collagen type I includes a het-
erotrimer and a homotrimer. Of note, the homotrimer is found only in fetal tissue, fibrosis,
and cancers, suggesting it is a relatively minor component; however, the structural and
mechanical differences have been discussed [25]. Our findings demonstrated considerable dif-
ference in the trimer components between the two rat strains, and Lewis rats tended to have
homotrimers more often than SD rats. We intend to evaluate the influences of the trimer com-
ponent differences on collagenase digestion in our next study. However, the present findings
suggest that the outcome of islet isolation with various ColG:ColH ratios and the composition
of homotrimeric Col I might be correlated. A quantitative investigation of α chain subtypes in
each collagen using MS may also be useful for analyzing collagen IV, since it consists of six α
chains. This may be an approach to evaluate the quantitative differences among donors.
In our study, the IHC technique was used to assess the expression of Col III and Col V in
pancreatic tissues. IHC staining is an established technique for detecting substances using a spe-
cific antibody and clarifying their distribution within tissues. Despite the isolation outcome sug-
gesting that Lewis rat pancreas contains more Col III than SD rat pancreas, IHC staining for
Col III did not reveal a stronger expression in Lewis rats. This is likely due to the technical char-
acteristics of our IHC evaluation. Since collagen has a triple-helical structure [26, 27] and IHC
staining only evaluates from a two-dimensional perspective, IHC staining can only detect the
part of the collagen structure that appears on the surface of pancreatic histological sections. As
Fig 5. Western blot analyses of Col III (A, B) and Col V (C, D) in the pancreatic tissues of each rat strain. The findings for SD
rats are presented as the percentage when those of Lewis rats were considered 100% (B, D). β-actin was used as a control (A, C).
https://doi.org/10.1371/journal.pone.0216136.g005
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such, target epitopes of the antibody may be inaccessible due to the native three-dimensional
conformation in the pancreas. Furthermore, IHC can only assess parts of the whole pancreatic
tissues. In support of this hypothesis, the results of Western blotting showed that Lewis rat pan-
creas contained substantially higher amounts of Col III than SD rat pancreas. This discrepancy
between the IHC and Western blot results may be due to the better exposure of the target linear
epitopes in the Western blot analysis and less sensitivity on quantification in the IHC.
To further evaluate the expression of Col III and Col V in pancreatic tissues, we assessed
Col3a1 and Col5a1 genes using real-time PCR. Of particular interest, the expression of Col5a1
was markedly lower than that of Col3a1, possibly due to the extreme importance of ColH in
rat pancreatic islet isolation [13]. The Col3a1 expression was slightly higher in Lewis rats than
in SD rats, whereas the expression of Col5a1 had no tendency to correlate with the outcome of
islet isolation. The Col3a1 expression tended to correlate with the isolation outcome, but the
difference was small and not significant. One possible explanation for the discrepancy between
the real-time PCR and Western blot findings may be the involvement of hydroxyproline. In
general, collagens include a hydroxyproline to stabilize the collagen triple helix. This hydroxy-
proline is produced during a post-translational modification process. The hydroxylation of
proline is not unified and can occur at any of several positions [28]. Although both the real-
time PCR and Western blot assays assessed the total amount of each collagen type, post-
Fig 6. MS Analyses of pancreatic tissues in each rat strain. (A) Col-I(α1)/Col-III(α1) ratio. (B) Col-I(α2)/Col-III(α1)
ratio. (C) Col-I(α1)/Col-I(α2) ratio.
https://doi.org/10.1371/journal.pone.0216136.g006
Strategy towards donor specific islet isolation
PLOS ONE | https://doi.org/10.1371/journal.pone.0216136 May 10, 2019 11 / 14
translational modification cannot be taken into consideration in real-time PCR. Therefore, the
difference between these real-time PCR and Western blot findings might be due at least in part
to a significant degree of hydroxylation for proline.
In summary, the present study revealed that an appropriate analysis technique taking the
three-dimensional structure of collagen into account is needed in order to accurately evaluate
the relative composition of collagen types in pancreatic tissues. Of particular note, the Col III
expression and/or the composition of homotrimeric Col I in pancreatic tissues using MS may
aid in the optimization of the ColG:ColH ratio. To establish a tailored donor-specific islet iso-
lation approach, further analyses of collagen subtypes in human pancreatic tissues using MS
are required.
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